| Title | Geography | Industry | ||||
|---|---|---|---|---|---|---|
| Number of ongoing Clinical Trials (for drugs) involving Short Bowel Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Ulcerative Colitis by Phase | Other Industry Indicators | Greece | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Constipation by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Eosinophilic Esophagitis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Diverticulitis by Phase | Other Industry Indicators | Norway | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Liver Fibrosis by Phase | Other Industry Indicators | South Korea | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pancreatitis by Phase | Other Industry Indicators | Denmark | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Inguinal Hernia by Phase | Other Industry Indicators | Nigeria | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Autoimmune Hepatitis by Phase | Other Industry Indicators | Norway | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Colitis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Gastroparesis by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Gastrointestinal by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Cirrhosis by Phase | Other Industry Indicators | Estonia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Motion Sickness by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Primary Sclerosing Cholangitis by Phase | Other Industry Indicators | France | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hernia by Phase | Other Industry Indicators | India | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Irritable Bowel Syndrome by Phase | Other Industry Indicators | Italy | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Nonerosive Reflux Disease (NERD) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Gall Stone by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Alcoholic Fatty Liver Disease by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hypersplenism by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hepatorenal Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Gastrointestinal Mucositis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Anorectal Disease by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Acidity by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Anal Fissure by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Biliary Atresia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Rectal Fistula by Phase | Other Industry Indicators | India | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Esophageal Achalasia by Phase | Other Industry Indicators | India | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Colonic Diverticulitis by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Liver Cirrhosis by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Systemic Mastocytosis by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Dumping Syndrome by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Appendicitis by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Liver Failure (Hepatic Insufficiency) by Phase | Other Industry Indicators | Estonia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Paralytic Ileus by Phase | Other Industry Indicators | Germany | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Crohn's Disease (Regional Enteritis) by Phase | Other Industry Indicators | Serbia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hepatomegaly by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Esophageal Motility Disorders by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Limited/Distal Colitis by Phase | Other Industry Indicators | Italy | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Ascites by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Gastric Motility Disorder by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Choledocholithiasis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Traveler's Diarrhea by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Stomach Function Disorder by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Duodenitis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Liver Diseases by Phase | Other Industry Indicators | Chile | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Peritonitis by Phase | Other Industry Indicators | India | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Necrotizing Enterocolitis by Phase | Other Industry Indicators | Singapore | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer